Skip to content
Multi Family OfficePuts its own capital into companiesLAST VERIFIED Oct 2026 · 2 SOURCES

FGP Capital

Geneva investment firm co-founded in 2009 that takes growth-capital stakes in late-stage university spin-offs, mainly in healthcare and industrial technology.

USEFUL FOR Business owners seeking a long-term partner · Co-investors

Identity

HEADQUARTERS
Geneva, Switzerland
FOUNDED
2009

Investment approach

GEOGRAPHY
Europe
STAGES
Growth
ROUTES
Companies (own capital)
STRATEGIES
Private equityDirect investments

Overview

FGP Capital SA is a Geneva firm co-founded in 2009 by Philippe Froehlicher, a former Pictet portfolio manager. It invests in late-stage spin-offs of universities and research institutes, focusing on growth-capital deals in healthcare (drug discovery, clinical-stage therapies) and disruptive industrial technology, using equity and convertible bonds with a target holding period of about three years. Holdings it lists include QuercisPharma, GeoSatis, Air'n and Theravectys, and it cites a past investment that listed on the London Stock Exchange (Oxford Nanopore).

Investment thesis

Late-stage growth companies from leading universities, close to cash-flow breakeven and ready for a trade sale or IPO, bought at European/Swiss valuations below US peers, with board involvement and exits targeted within roughly three years.

Holdings & investments (5)

  • QuercisPharma
    Biotech & Life Sciences
  • GeoSatis
    Industrial & Manufacturing
  • Air'n
  • Theravectys
    Biotech & Life Sciences
  • Biotech & Life Sciences · IPO

People

  • Philippe Froehlicher
    Co-founder, Managing Partner · source
  • Richard Ormond
    Managing Partner · source

Frequently asked questions

FGP Capital is a multi family office based in Geneva, Switzerland, founded in 2009.

FGP Capital invests its own capital into companies. Its stated asset mix includes private equity and direct investments.

FGP Capital invests at Growth stage in Biotech & Life Sciences, HealthTech and Industrial & Manufacturing.

Key people at FGP Capital include Philippe Froehlicher (Co-founder, Managing Partner) and Richard Ormond (Managing Partner).

FGP Capital's holdings and investments include QuercisPharma, GeoSatis, Air'n, Theravectys and Oxford Nanopore Technologies.